(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDIPLUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MEDIPLUS

ST13

US500000079100628

Class

5, 10

Filing

79100628

Registration

4177558

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

55

Latest update

05/08/2025

Trademark type

Combined

Nice classes

5, 10

Filing date

06/03/2011

Registration date

07/24/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/04/2022

Last transaction

05/08/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

Singapore, SG

Examiner

JUN,WON KYUNG WENDY

Law office

L30

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the wording "MEDIPLUS". The letter "I" consists of two dots, one at the top and the one at the bottom and is inside a shaded rectangle.

Holders and representatives

Holders

MEDIPURPOSE PTE. LTD.
MEDIPURPOSE PTE. LTD.

Representatives

Austin Padgett, Esq. Troutman Sanders LLP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Hydrocolloid adhesive wound dressingadhesive dressings for medical purposes; polyurethane dressings for medical purposes; polyurethane dressings for use as medical dressingspolyurethane foam bandages for dressingsalginate wound dressings; surgical dressings incorporating collagengauzeskin care creams for medical use-casts for orthopaedic purposes; adhesive for bandages for skin wounds; sterilized medical dressing for use in or after intravenous administration; non-adherent medical dressing; post-operative surgical dressings; medicated pre-moistened wipes for surgical use; transparent medical dressing; first aid bandages for dressingsdressings for skin wounds-dressing with hydrogel for skin wounds

Class 10

Supportive bandagessuspensory bandageselastic bandages; medical apparatus for managing wound caredevices for measuring woundswound drainage apparatuswound suction apparatus; surgical drapesself-adhesive drapes for surgical use; surgical drapessurgical drape sheets for use in locating incision field; compression bandages; plaster casts for orthopedic purposes

Publications

History of USPTO decisions and trademark events.

55 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/11/2025

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

10/23/2023

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

09/02/2023

INPC

INVALIDATION PROCESSED

09/02/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

08/04/2023

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

12/05/2022

71AG

REGISTERED-SEC.71 ACCEPTED

12/04/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/22/2022

ES71

TEAS SECTION 71 RECEIVED

06/13/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/27/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

07/24/2021

RNWL

INTERNATIONAL REGISTRATION RENEWED

06/17/2021

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

08/25/2020

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

07/10/2020

INPC

INVALIDATION PROCESSED

07/10/2020

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

06/23/2020

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

10/23/2019

71AG

REGISTERED-SEC.71 ACCEPTED

10/23/2019

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

10/11/2019

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

09/06/2019

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

08/14/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/01/2019

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

07/19/2019

PR71

POST REGISTRATION ACTION MAILED - SEC.71

01/23/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/20/2018

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

09/24/2018

PR71

POST REGISTRATION ACTION MAILED - SEC.71

03/24/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/09/2018

ES71

TEAS SECTION 71 RECEIVED

03/02/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/26/2016

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/18/2012

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/26/2012

FIMP

FINAL DISPOSITION PROCESSED

10/26/2012

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/24/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

07/24/2012

PUBO

PUBLISHED FOR OPPOSITION

05/08/2012

NPUB

NOTICE OF PUBLICATION

04/18/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/31/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/28/2012

CNEA

EXAMINERS AMENDMENT MAILED

03/28/2012

XAEC

EXAMINER'S AMENDMENT ENTERED

03/28/2012

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/28/2012

ACEC

AMENDMENT FROM APPLICANT ENTERED

03/26/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/26/2012

ALIE

ASSIGNED TO LIE

03/13/2012

MAIL

PAPER RECEIVED

02/23/2012

RFNT

REFUSAL PROCESSED BY IB

10/09/2011

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/21/2011

RFRR

REFUSAL PROCESSED BY MPU

09/21/2011

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/21/2011

CNRT

NON-FINAL ACTION WRITTEN

09/20/2011

DOCK

ASSIGNED TO EXAMINER

09/19/2011

MAFR

APPLICATION FILING RECEIPT MAILED

08/23/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/19/2011

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/18/2011

Continuous trademark protection

Get notified about every new filing that threatens MEDIPLUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.